Doximity, Inc. (NYSE: DOCS) Stock Competitors & Peer Comparison

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while GEHCV trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas GEHCV's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, DOCS is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check GEHCV's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, BTSG has a market cap of 11.8B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while BTSG trades at $60.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas BTSG's P/E ratio is 48.59. In terms of profitability, DOCS's ROE is +0.17%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, DOCS is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check BTSG's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, BTSGU has a market cap of 11.7B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while BTSGU trades at $198.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas BTSGU's P/E ratio is 179.93. In terms of profitability, DOCS's ROE is +0.17%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, DOCS is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check BTSGU's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, TEM has a market cap of 10.9B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while TEM trades at $61.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas TEM's P/E ratio is -123.88. In terms of profitability, DOCS's ROE is +0.17%, compared to TEM's ROE of -0.55%. Regarding short-term risk, DOCS is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check TEM's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while SGFY trades at $30.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas SGFY's P/E ratio is 70.91. In terms of profitability, DOCS's ROE is +0.17%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, DOCS is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check SGFY's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, HQY has a market cap of 8.2B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while HQY trades at $98.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas HQY's P/E ratio is 23.02. In terms of profitability, DOCS's ROE is +0.17%, compared to HQY's ROE of +0.11%. Regarding short-term risk, DOCS is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check HQY's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, TXG has a market cap of 7.8B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while TXG trades at $61.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas TXG's P/E ratio is -104.49. In terms of profitability, DOCS's ROE is +0.17%, compared to TXG's ROE of -0.09%. Regarding short-term risk, DOCS is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check TXG's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, HNGE has a market cap of 7.1B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while HNGE trades at $91.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas HNGE's P/E ratio is 49.11. In terms of profitability, DOCS's ROE is +0.17%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, DOCS is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check HNGE's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while RCM trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas RCM's P/E ratio is -102.21. In terms of profitability, DOCS's ROE is +0.17%, compared to RCM's ROE of +0.00%. Regarding short-term risk, DOCS is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check RCM's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, WAY has a market cap of 4.9B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while WAY trades at $25.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas WAY's P/E ratio is 17.03. In terms of profitability, DOCS's ROE is +0.17%, compared to WAY's ROE of +0.04%. Regarding short-term risk, DOCS is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check WAY's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, HTFL has a market cap of 4.3B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while HTFL trades at $50.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas HTFL's P/E ratio is -24.88. In terms of profitability, DOCS's ROE is +0.17%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, DOCS is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check HTFL's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while ONEM trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas ONEM's P/E ratio is -7.77. In terms of profitability, DOCS's ROE is +0.17%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, DOCS is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check ONEM's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, PRVA has a market cap of 2.6B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while PRVA trades at $20.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas PRVA's P/E ratio is 98.67. In terms of profitability, DOCS's ROE is +0.17%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, DOCS is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check PRVA's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while NXGN trades at $23.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas NXGN's P/E ratio is -266.00. In terms of profitability, DOCS's ROE is +0.17%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, DOCS is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check NXGN's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, OMCL has a market cap of 1.6B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while OMCL trades at $34.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas OMCL's P/E ratio is 18.18. In terms of profitability, DOCS's ROE is +0.17%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, DOCS is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check OMCL's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while OMDA trades at $23.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas OMDA's P/E ratio is 333.00. In terms of profitability, DOCS's ROE is +0.17%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, DOCS is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check OMDA's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while AGTI trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas AGTI's P/E ratio is -71.79. In terms of profitability, DOCS's ROE is +0.17%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, DOCS is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check AGTI's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CERT trades at $8.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CERT's P/E ratio is 20.70. In terms of profitability, DOCS's ROE is +0.17%, compared to CERT's ROE of -0.07%. Regarding short-term risk, DOCS is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check CERT's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while GDRX trades at $3.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas GDRX's P/E ratio is 10.78. In terms of profitability, DOCS's ROE is +0.17%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, DOCS is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check GDRX's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while TDOC trades at $6.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas TDOC's P/E ratio is -6.52. In terms of profitability, DOCS's ROE is +0.17%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, DOCS is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check TDOC's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, HSTM has a market cap of 869.7M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while HSTM trades at $29.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas HSTM's P/E ratio is 41.35. In terms of profitability, DOCS's ROE is +0.17%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, DOCS is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check HSTM's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CCLDO trades at $27.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CCLDO's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, DOCS is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CCLDO's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, PHR has a market cap of 734.3M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while PHR trades at $11.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas PHR's P/E ratio is 42.43. In terms of profitability, DOCS's ROE is +0.17%, compared to PHR's ROE of +0.03%. Regarding short-term risk, DOCS is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check PHR's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, SOPH has a market cap of 694.7M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while SOPH trades at $8.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas SOPH's P/E ratio is -7.46. In terms of profitability, DOCS's ROE is +0.17%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, DOCS is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SOPH's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CTEV has a market cap of 685.8M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CTEV trades at $40.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CTEV's P/E ratio is -2.37. In terms of profitability, DOCS's ROE is +0.17%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, DOCS is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check CTEV's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while MPLN-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, DOCS is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check MPLN-WT's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while ACCD trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas ACCD's P/E ratio is -3.08. In terms of profitability, DOCS's ROE is +0.17%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, DOCS is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check ACCD's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while SHCR trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas SHCR's P/E ratio is -3.76. In terms of profitability, DOCS's ROE is +0.17%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, DOCS is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check SHCR's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, EVH has a market cap of 475.2M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while EVH trades at $4.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas EVH's P/E ratio is 32.50. In terms of profitability, DOCS's ROE is +0.17%, compared to EVH's ROE of -0.99%. Regarding short-term risk, DOCS is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check EVH's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, NRC has a market cap of 451M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while NRC trades at $20.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas NRC's P/E ratio is 24.40. In terms of profitability, DOCS's ROE is +0.17%, compared to NRC's ROE of +0.48%. Regarding short-term risk, DOCS is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check NRC's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while SLGCW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, DOCS's ROE is +0.17%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, DOCS is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SLGCW's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while SLGC trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas SLGC's P/E ratio is -3.04. In terms of profitability, DOCS's ROE is +0.17%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, DOCS is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SLGC's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while TBRG trades at $26.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas TBRG's P/E ratio is 9.37. In terms of profitability, DOCS's ROE is +0.17%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, DOCS is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check TBRG's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while MPLN trades at $23.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas MPLN's P/E ratio is -0.23. In terms of profitability, DOCS's ROE is +0.17%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, DOCS is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check MPLN's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, SY has a market cap of 370M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while SY trades at $2.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas SY's P/E ratio is -8.55. In terms of profitability, DOCS's ROE is +0.17%, compared to SY's ROE of -0.16%. Regarding short-term risk, DOCS is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SY's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while TRHC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas TRHC's P/E ratio is -4.27. In terms of profitability, DOCS's ROE is +0.17%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, DOCS is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check TRHC's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while SMFR trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas SMFR's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, DOCS is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SMFR's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, SPOK has a market cap of 220.6M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while SPOK trades at $10.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas SPOK's P/E ratio is 17.60. In terms of profitability, DOCS's ROE is +0.17%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, DOCS is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check SPOK's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, AMWL has a market cap of 218.2M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while AMWL trades at $12.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas AMWL's P/E ratio is -2.90. In terms of profitability, DOCS's ROE is +0.17%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, DOCS is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check AMWL's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, LFMDP has a market cap of 160.2M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while LFMDP trades at $23.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas LFMDP's P/E ratio is -724.19. In terms of profitability, DOCS's ROE is +0.17%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, DOCS is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check LFMDP's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, OPRX has a market cap of 150.9M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while OPRX trades at $8.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas OPRX's P/E ratio is 7.38. In terms of profitability, DOCS's ROE is +0.17%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, DOCS is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check OPRX's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, LFMD has a market cap of 148.5M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while LFMD trades at $3.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas LFMD's P/E ratio is -6.14. In terms of profitability, DOCS's ROE is +0.17%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, DOCS is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check LFMD's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CPSI trades at $9.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CPSI's P/E ratio is -183.80. In terms of profitability, DOCS's ROE is +0.17%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, DOCS is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check CPSI's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, HCAT has a market cap of 124.9M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while HCAT trades at $1.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas HCAT's P/E ratio is 8.45. In terms of profitability, DOCS's ROE is +0.17%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, DOCS is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check HCAT's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while AUGX trades at $2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas AUGX's P/E ratio is -4.99. In terms of profitability, DOCS's ROE is +0.17%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, DOCS is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check AUGX's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, DH has a market cap of 109.7M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while DH trades at $1.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas DH's P/E ratio is 4.00. In terms of profitability, DOCS's ROE is +0.17%, compared to DH's ROE of -0.79%. Regarding short-term risk, DOCS is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check DH's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CCLD has a market cap of 95.2M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CCLD trades at $2.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CCLD's P/E ratio is 8.62. In terms of profitability, DOCS's ROE is +0.17%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, DOCS is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check CCLD's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, WORX has a market cap of 88M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while WORX trades at $5.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas WORX's P/E ratio is -6.40. In terms of profitability, DOCS's ROE is +0.17%, compared to WORX's ROE of -0.35%. Regarding short-term risk, DOCS is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check WORX's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while FORA trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas FORA's P/E ratio is -24.11. In terms of profitability, DOCS's ROE is +0.17%, compared to FORA's ROE of -0.17%. Regarding short-term risk, DOCS is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check FORA's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CCLDP trades at $19.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CCLDP's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, DOCS is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CCLDP's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while SNCE trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas SNCE's P/E ratio is -0.27. In terms of profitability, DOCS's ROE is +0.17%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, DOCS is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check SNCE's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while AKLI trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas AKLI's P/E ratio is -0.71. In terms of profitability, DOCS's ROE is +0.17%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, DOCS is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check AKLI's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while SHLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas SHLT's P/E ratio is -3.87. In terms of profitability, DOCS's ROE is +0.17%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, DOCS is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check SHLT's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, ONMD has a market cap of 32.9M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while ONMD trades at $0.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas ONMD's P/E ratio is -3.61. In terms of profitability, DOCS's ROE is +0.17%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, DOCS is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check ONMD's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while SHCRW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, DOCS's ROE is +0.17%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, DOCS is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SHCRW's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, ONMDW has a market cap of 30.2M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while ONMDW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas ONMDW's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, DOCS is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check ONMDW's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while STRM trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas STRM's P/E ratio is -2.40. In terms of profitability, DOCS's ROE is +0.17%, compared to STRM's ROE of -0.65%. Regarding short-term risk, DOCS is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check STRM's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while RNLX trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas RNLX's P/E ratio is -0.33. In terms of profitability, DOCS's ROE is +0.17%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, DOCS is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check RNLX's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while LIFW trades at $3.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas LIFW's P/E ratio is -0.02. In terms of profitability, DOCS's ROE is +0.17%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, DOCS is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check LIFW's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while BBLN trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas BBLN's P/E ratio is -0.04. In terms of profitability, DOCS's ROE is +0.17%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, DOCS is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check BBLN's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while ETAO trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas ETAO's P/E ratio is -0.01. In terms of profitability, DOCS's ROE is +0.17%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, DOCS is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check ETAO's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, BFRG has a market cap of 9.1M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while BFRG trades at $0.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas BFRG's P/E ratio is -1.07. In terms of profitability, DOCS's ROE is +0.17%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, DOCS is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check BFRG's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, MGRX has a market cap of 6.5M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while MGRX trades at $0.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas MGRX's P/E ratio is -0.28. In terms of profitability, DOCS's ROE is +0.17%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, DOCS is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check MGRX's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while UPH trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas UPH's P/E ratio is -0.07. In terms of profitability, DOCS's ROE is +0.17%, compared to UPH's ROE of -1.05%. Regarding short-term risk, DOCS is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check UPH's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while UPH-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, DOCS is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check UPH-WT's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while PEAR trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas PEAR's P/E ratio is -0.08. In terms of profitability, DOCS's ROE is +0.17%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, DOCS is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check PEAR's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while PEARW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas PEARW's P/E ratio is -0.00. In terms of profitability, DOCS's ROE is +0.17%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, DOCS is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check PEARW's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while OTRK trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas OTRK's P/E ratio is -0.02. In terms of profitability, DOCS's ROE is +0.17%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, DOCS is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check OTRK's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CMAX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CMAX's P/E ratio is -0.00. In terms of profitability, DOCS's ROE is +0.17%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, DOCS is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CMAX's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while BFRGW trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas BFRGW's P/E ratio is -0.92. In terms of profitability, DOCS's ROE is +0.17%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, DOCS is less volatile compared to BFRGW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check BFRGW's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while LIFWZ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, DOCS is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check LIFWZ's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, ACON has a market cap of 1.2M. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while ACON trades at $2.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas ACON's P/E ratio is -0.26. In terms of profitability, DOCS's ROE is +0.17%, compared to ACON's ROE of -0.59%. Regarding short-term risk, DOCS is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check ACON's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, HCTI has a market cap of 947.8K. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while HCTI trades at $0.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas HCTI's P/E ratio is -0.10. In terms of profitability, DOCS's ROE is +0.17%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, DOCS is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check HCTI's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while VSEEW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, DOCS's ROE is +0.17%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, DOCS is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check VSEEW's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while MSPRZ trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, DOCS is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check MSPRZ's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, VSEE has a market cap of 274.9K. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while VSEE trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas VSEE's P/E ratio is -0.04. In terms of profitability, DOCS's ROE is +0.17%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, DOCS is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check VSEE's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while KERNW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas KERNW's P/E ratio is -0.00. In terms of profitability, DOCS's ROE is +0.17%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, DOCS is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check KERNW's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while KERN trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas KERN's P/E ratio is -0.01. In terms of profitability, DOCS's ROE is +0.17%, compared to KERN's ROE of -0.20%. Regarding short-term risk, DOCS is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check KERN's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while LIFWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas LIFWW's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, DOCS is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check LIFWW's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CMAXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CMAXW's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, DOCS is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CMAXW's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, ZCMD has a market cap of 31.2K. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while ZCMD trades at $0.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, DOCS's ROE is +0.17%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, DOCS is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check ZCMD's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, ACONW has a market cap of 18.7K. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while ACONW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas ACONW's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, DOCS is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check ACONW's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while MTBC trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas MTBC's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, DOCS is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check MTBC's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while MTBCP trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas MTBCP's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, DOCS is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check MTBCP's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while MTBCO trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas MTBCO's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, DOCS is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check MTBCO's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CNVY trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CNVY's P/E ratio is -71.50. In terms of profitability, DOCS's ROE is +0.17%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, DOCS is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CNVY's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, NH has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while NH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas NH's P/E ratio is -0.12. In terms of profitability, DOCS's ROE is +0.17%, compared to NH's ROE of +0.35%. Regarding short-term risk, DOCS is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check NH's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CERN has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CERN trades at $94.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CERN's P/E ratio is 55.84. In terms of profitability, DOCS's ROE is +0.17%, compared to CERN's ROE of +0.14%. Regarding short-term risk, DOCS is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CERN's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, KURIU has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while KURIU trades at $9.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas KURIU's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, DOCS is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check KURIU's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CHNG trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CHNG's P/E ratio is -152.72. In terms of profitability, DOCS's ROE is +0.17%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, DOCS is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CHNG's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, AFFX has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while AFFX trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas AFFX's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, DOCS is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check AFFX's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CHNGU trades at $73.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CHNGU's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, DOCS is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CHNGU's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while CSLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas CSLT's P/E ratio is -37.27. In terms of profitability, DOCS's ROE is +0.17%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, DOCS is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for DOCS.Check CSLT's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while NAVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas NAVA's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, DOCS is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for DOCS.Check NAVA's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, IMS has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while IMS trades at $31.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas IMS's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to IMS's ROE of +0.27%. Regarding short-term risk, DOCS is less volatile compared to IMS. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check IMS's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while SMFRW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas SMFRW's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, DOCS is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check SMFRW's competition here

Doximity, Inc. (NYSE: DOCS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCS stands at 4.9B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, DOCS is priced at $26.32 on the NYSE, while MSPRV trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCS currently has a P/E ratio of 17.20, whereas MSPRV's P/E ratio is N/A. In terms of profitability, DOCS's ROE is +0.17%, compared to MSPRV's ROE of N/A. Regarding short-term risk, DOCS is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for DOCS.Check MSPRV's competition here